Oncolytics Biotech, Inc (ONCY) last year’s performance of 23.66% is a clear signal for an entertaining trading season.

On Tuesday, Oncolytics Biotech, Inc (NASDAQ: ONCY) was -5.83% drop from the session before settling in for the closing price of $1.2. A 52-week range for ONCY has been $0.33 – $1.53.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Healthcare Sector giant saw their annual sales surged by 23.13% over the last five years. When this article was written, the company’s average yearly earnings per share was at 3.87%. With a float of $93.51 million, this company’s outstanding shares have now reached $96.60 million.

The firm has a total of 28 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.

Oncolytics Biotech, Inc (ONCY) Breakdown of a Key Holders of the stock

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Oncolytics Biotech, Inc stocks. The insider ownership of Oncolytics Biotech, Inc is 3.20%, while institutional ownership is 9.89%.

Oncolytics Biotech, Inc (ONCY) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 3.87% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.78% during the next five years compared to 23.13% growth over the previous five years of trading.

Oncolytics Biotech, Inc (NASDAQ: ONCY) Trading Performance Indicators

You can see what Oncolytics Biotech, Inc (ONCY) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.21.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.29, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.28 in one year’s time.

Technical Analysis of Oncolytics Biotech, Inc (ONCY)

Analysing the last 5-days average volume posted by the [Oncolytics Biotech, Inc, ONCY], we can find that recorded value of 1.34 million was better than the volume posted last year of 1.0 million. As of the previous 9 days, the stock’s Stochastic %D was 76.67%.

During the past 100 days, Oncolytics Biotech, Inc’s (ONCY) raw stochastic average was set at 81.71%, which indicates a significant increase from 72.31% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1223 in the past 14 days, which was higher than the 0.0580 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.6242, while its 200-day Moving Average is $0.7871. Now, the first resistance to watch is $1.1833. This is followed by the second major resistance level at $1.2367. The third major resistance level sits at $1.2733. If the price goes on to break the first support level at $1.0933, it is likely to go to the next support level at $1.0567. Now, if the price goes above the second support level, the third support stands at $1.0033.

Oncolytics Biotech, Inc (NASDAQ: ONCY) Key Stats

There are 94,284K outstanding shares of the company, which has a market capitalization of 109.16 million. As of now, sales total 0 K while income totals -23,140 K. Its latest quarter income was 0 K while its last quarter net income were -4,660 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.